Search

everythinglearnresearchcommunity

for

Search:↓

Scalp cryotherapy significantly reduces hair loss during and shortly after chemotherapy.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

High-dose methotrexate can cause severe skin and nail issues.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Cold caps and certain drugs may help prevent or reduce hair loss from chemotherapy, but more research is needed.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

A man developed alopecia areata after starting cancer treatment with vandetanib.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Most pediatric cancer patients in the study developed skin problems, often due to their cancer treatment.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

The conclusion is to use scalp cooling, gentle hair care, and treatments like minoxidil for managing hair loss from chemotherapy, and stresses the need for more research and collaboration in this area.

A patient with Cronkhite-Canada Syndrome developed colon cancer that spread to the liver, showing the need for regular cancer checks in such patients.

Boosting certain cell signals can prevent hair loss from chemotherapy and radiation.

Acitretin treats severe skin conditions but requires careful monitoring due to serious side effects.

Many medications can cause hair loss or excessive hair growth, which is usually reversible after stopping the drug.

Rituximab effectively treated a woman's bone lymphoma that was resistant to other treatments.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

Low-dose oral minoxidil combined with topical minoxidil improves hair density in breast cancer patients but may cause excess hair growth.

Some breast cancer treatments cause hair loss similar to male pattern baldness, which can be improved with minoxidil.

Eliminating senescent cells can prevent and reverse chemotherapy-induced peripheral neuropathy.

Exercise may help reduce treatment side effects and improve survival in metastatic colorectal cancer.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Aldactone was more effective in reducing hair growth in women with hirsutism than Diane, despite having less impact on hormone levels.

Hormonal treatments effectively manage acne in some women, especially with specific hormonal issues.

Photodynamic therapy is the preferred treatment for skin precancer due to its effectiveness and safety.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

Tumor-targeted drug carriers can improve chemotherapy precision and reduce side effects.

Blocking certain immune signals can reduce skin damage from radiation therapy.